← Back to headlines
Veracyte Projects 10%–13% Revenue Growth for 2026
Veracyte anticipates a revenue growth of 10%–13% for 2026, driven by the advancement of its MRD and Prosigna product launches.
26 Feb, 03:18 — 26 Feb, 03:18
ℹOnly 1 source covers this story
